#alphafold

Isomorphic Labs, the DeepMind spin-off focused on AI-driven drug discovery, has unveiled a new AI that scientists are calling a generational leap comparable to AlphaFold.

Google DeepMind spin-off Isomorphic Labs published a technical report on IsoDDE, a proprietary drug discovery AI that scientists are comparing to a hypothetical AlphaFold 4. The model excels at predicting protein-drug binding and has secured billion-dollar deals with J&J, Eli Lilly, and Novartis.

Google DeepMind spinoff Isomorphic Labs revealed IsoDDE, an AI drug design engine that more than doubles AlphaFold 3's accuracy. It reduces drug discovery timelines from years to months, transforming pharmaceutical R&D.